setmelanotide vs tirzepatide What's New in Obesity Treatment? Dr. Tashko's Key Clinical Trials

J., Cao, X

About the author: GLP-1 medications like Ozempic, Mounjaro, and Wegovy have revolutionized weight loss treatment, offering unprecedented success rates for patients struggling with obesity and metabolic dysfunction

The OASIS 4 trial was the key efficacy study for the oral tablet, and most of what we know about its side effect profile comes from that research

The scale of these shifts is still evolving, but the direction is clear: eating patterns are changing, and no category is immune." Rabo quoted a US study that showed households with at least one user of these medicines reduced their grocery spending by 6 per cent within six months

individuals with pre-existing retinopathy should be aware of this risk [28] [29] Pregnancy and breastfeeding incretin-based therapies should be avoided during pregnancy and breastfeeding unless within a supervised clinical trial, as safety data in these populations are absent Delayed gastric emptying a class effect of GLP-1 receptor agonists can reduce the absorption rate of concomitant oral medicines